Dissecting PTPN7‐driven aggressiveness in IDH‐wildtype astrocytomas: multi‐omics, clinical validation, and spatial transcriptomics for prognostic insights
Abstract Background Gliomas, particularly IDH‐wildtype astrocytomas, remain highly aggressive and resistant to current therapies. Despite advances in molecular classification, effective therapeutic targets are still limited. Consequently, identifying new targets is essential to improve patient survi...
Saved in:
| Main Authors: | Tung Liu, Yu-Chieh Lin, Pei-Chi Chang, Dueng-Yuan Hueng, Yao-Feng Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02662-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A potential tumor suppressor role of PLK2 in glioblastoma
by: Xiangping Xia, et al.
Published: (2025-05-01) -
NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes
by: Michael Chang, et al.
Published: (2024-10-01) -
Multi-task glioma segmentation and IDH mutation and 1p19q codeletion classification via a deep learning model on multimodal MRI
by: Erin Beate Bjørkeli, et al.
Published: (2025-06-01) -
Comparative Clinical-Imaging and Histogenetic Analysis Between Astrocytoma IDH-Mutant Grade 4 and Glioblastoma IDH-Wildtype—Is There Really a Worse One?
by: Cristian Ionut Orasanu, et al.
Published: (2025-02-01) -
PTPN22 polymorphisms associated with type 1 diabetes mellitus in ethnic populations of Russian Federation
by: O N Ivanova, et al.
Published: (2013-06-01)